HIV Infection and Immunosuppressive Disorders
SJR0.200
RU
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.200 | Q4 | 27.9% | |
| 2024 | — | — | 0.146 | Q4 | 18.9% | |
| 2023 | — | — | 0.149 | Q4 | 24.9% | |
| 2022 | — | — | 0.150 | Q4 | 28.5% | |
| 2021 | — | — | 0.137 | Q4 | 27.8% | |
| 2020 | — | — | 0.176 | Q4 | 30.0% | |
| 2019 | — | — | 0.239 | Q4 | 45.0% | |
| 2018 | — | — | 0.189 | Q4 | 32.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2077-9828
ISSN
2078-1792
country
coverage
2017-2025